Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Plasma-derived Therapies Revenue

1.5 Market Analysis by Type

1.5.1 Global Plasma-derived Therapies Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Albumin

1.5.3 Immunoglobulin

1.5.4 Factor VIII

1.5.5 Others

1.6 Market by Application

1.6.1 Global Plasma-derived Therapies Market Share by Application: 2022-2027

1.6.2 Hemophilia

1.6.3 Primary Immunodeficiencies (PIDs)

1.6.4 Idiopathic Thrombocytopenic Purpura (ITP)

1.6.5 COVID-19

1.6.6 Others

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Plasma-derived Therapies Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Plasma-derived Therapies Market Players Profiles

3.1 CSL Behring LLC

3.1.1 CSL Behring LLC Company Profile

3.1.2 CSL Behring LLC Plasma-derived Therapies Product Specification

3.1.3 CSL Behring LLC Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Bio Products Laboratory (BPL)

3.2.1 Bio Products Laboratory (BPL) Company Profile

3.2.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Specification

3.2.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Kedrion

3.3.1 Kedrion Company Profile

3.3.2 Kedrion Plasma-derived Therapies Product Specification

3.3.3 Kedrion Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Shire

3.4.1 Shire Company Profile

3.4.2 Shire Plasma-derived Therapies Product Specification

3.4.3 Shire Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Octaparma

3.5.1 Octaparma Company Profile

3.5.2 Octaparma Plasma-derived Therapies Product Specification

3.5.3 Octaparma Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Bayer

3.6.1 Bayer Company Profile

3.6.2 Bayer Plasma-derived Therapies Product Specification

3.6.3 Bayer Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Grifols

3.7.1 Grifols Company Profile

3.7.2 Grifols Plasma-derived Therapies Product Specification

3.7.3 Grifols Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Biotest

3.8.1 Biotest Company Profile

3.8.2 Biotest Plasma-derived Therapies Product Specification

3.8.3 Biotest Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Takeda

3.9.1 Takeda Company Profile

3.9.2 Takeda Plasma-derived Therapies Product Specification

3.9.3 Takeda Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 LFB

3.10.1 LFB Company Profile

3.10.2 LFB Plasma-derived Therapies Product Specification

3.10.3 LFB Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Plasma-derived Therapies Market Competition by Market Players

4.1 Global Plasma-derived Therapies Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Plasma-derived Therapies Revenue Market Share by Market Players (2016-2021)

4.3 Global Plasma-derived Therapies Average Price by Market Players (2016-2021)

5 Global Plasma-derived Therapies Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Plasma-derived Therapies Market Size (2016-2021)

5.1.2 Plasma-derived Therapies Key Players in North America (2016-2021)

5.1.3 North America Plasma-derived Therapies Market Size by Type (2016-2021)

5.1.4 North America Plasma-derived Therapies Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Plasma-derived Therapies Market Size (2016-2021)

5.2.2 Plasma-derived Therapies Key Players in East Asia (2016-2021)

5.2.3 East Asia Plasma-derived Therapies Market Size by Type (2016-2021)

5.2.4 East Asia Plasma-derived Therapies Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Plasma-derived Therapies Market Size (2016-2021)

5.3.2 Plasma-derived Therapies Key Players in Europe (2016-2021)

5.3.3 Europe Plasma-derived Therapies Market Size by Type (2016-2021)

5.3.4 Europe Plasma-derived Therapies Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Plasma-derived Therapies Market Size (2016-2021)

5.4.2 Plasma-derived Therapies Key Players in South Asia (2016-2021)

5.4.3 South Asia Plasma-derived Therapies Market Size by Type (2016-2021)

5.4.4 South Asia Plasma-derived Therapies Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Plasma-derived Therapies Market Size (2016-2021)

5.5.2 Plasma-derived Therapies Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Plasma-derived Therapies Market Size by Type (2016-2021)

5.5.4 Southeast Asia Plasma-derived Therapies Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Plasma-derived Therapies Market Size (2016-2021)

5.6.2 Plasma-derived Therapies Key Players in Middle East (2016-2021)

5.6.3 Middle East Plasma-derived Therapies Market Size by Type (2016-2021)

5.6.4 Middle East Plasma-derived Therapies Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Plasma-derived Therapies Market Size (2016-2021)

5.7.2 Plasma-derived Therapies Key Players in Africa (2016-2021)

5.7.3 Africa Plasma-derived Therapies Market Size by Type (2016-2021)

5.7.4 Africa Plasma-derived Therapies Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Plasma-derived Therapies Market Size (2016-2021)

5.8.2 Plasma-derived Therapies Key Players in Oceania (2016-2021)

5.8.3 Oceania Plasma-derived Therapies Market Size by Type (2016-2021)

5.8.4 Oceania Plasma-derived Therapies Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Plasma-derived Therapies Market Size (2016-2021)

5.9.2 Plasma-derived Therapies Key Players in South America (2016-2021)

5.9.3 South America Plasma-derived Therapies Market Size by Type (2016-2021)

5.9.4 South America Plasma-derived Therapies Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Plasma-derived Therapies Market Size (2016-2021)

5.10.2 Plasma-derived Therapies Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Plasma-derived Therapies Market Size by Type (2016-2021)

5.10.4 Rest of the World Plasma-derived Therapies Market Size by Application (2016-2021)

6 Global Plasma-derived Therapies Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Plasma-derived Therapies Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Plasma-derived Therapies Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Plasma-derived Therapies Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Plasma-derived Therapies Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Plasma-derived Therapies Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Plasma-derived Therapies Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Plasma-derived Therapies Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Plasma-derived Therapies Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Plasma-derived Therapies Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Plasma-derived Therapies Consumption by Countries

7 Global Plasma-derived Therapies Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Plasma-derived Therapies (2022-2027)

7.2 Global Forecasted Revenue of Plasma-derived Therapies (2022-2027)

7.3 Global Forecasted Price of Plasma-derived Therapies (2022-2027)

7.4 Global Forecasted Production of Plasma-derived Therapies by Region (2022-2027)

7.4.1 North America Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.3 Europe Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.7 Africa Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.9 South America Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Plasma-derived Therapies Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Plasma-derived Therapies by Application (2022-2027)

8 Global Plasma-derived Therapies Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Plasma-derived Therapies by Country

8.2 East Asia Market Forecasted Consumption of Plasma-derived Therapies by Country

8.3 Europe Market Forecasted Consumption of Plasma-derived Therapies by Countriy

8.4 South Asia Forecasted Consumption of Plasma-derived Therapies by Country

8.5 Southeast Asia Forecasted Consumption of Plasma-derived Therapies by Country

8.6 Middle East Forecasted Consumption of Plasma-derived Therapies by Country

8.7 Africa Forecasted Consumption of Plasma-derived Therapies by Country

8.8 Oceania Forecasted Consumption of Plasma-derived Therapies by Country

8.9 South America Forecasted Consumption of Plasma-derived Therapies by Country

8.10 Rest of the world Forecasted Consumption of Plasma-derived Therapies by Country

9 Global Plasma-derived Therapies Sales by Type (2016-2027)

9.1 Global Plasma-derived Therapies Historic Market Size by Type (2016-2021)

9.2 Global Plasma-derived Therapies Forecasted Market Size by Type (2022-2027)

10 Global Plasma-derived Therapies Consumption by Application (2016-2027)

10.1 Global Plasma-derived Therapies Historic Market Size by Application (2016-2021)

10.2 Global Plasma-derived Therapies Forecasted Market Size by Application (2022-2027)

11 Global Plasma-derived Therapies Manufacturing Cost Analysis

11.1 Plasma-derived Therapies Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Plasma-derived Therapies

12 Global Plasma-derived Therapies Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Plasma-derived Therapies Distributors List

12.3 Plasma-derived Therapies Customers

12.4 Plasma-derived Therapies Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Plasma-derived Therapies Revenue (US$ Million) 2016-2021

Table 6. Global Plasma-derived Therapies Market Size by Type (US$ Million): 2022-2027

Table 7. Albumin Features

Table 8. Immunoglobulin Features

Table 9. Factor VIII Features

Table 10. Others Features

Table 16. Global Plasma-derived Therapies Market Size by Application (US$ Million): 2022-2027

Table 17. Hemophilia Case Studies

Table 18. Primary Immunodeficiencies (PIDs) Case Studies

Table 19. Idiopathic Thrombocytopenic Purpura (ITP) Case Studies

Table 20. COVID-19 Case Studies

Table 21. Others Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Plasma-derived Therapies Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Plasma-derived Therapies Market Growth Strategy

Table 46. Plasma-derived Therapies SWOT Analysis

Table 47. CSL Behring LLC Plasma-derived Therapies Product Specification

Table 48. CSL Behring LLC Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Bio Products Laboratory (BPL) Plasma-derived Therapies Product Specification

Table 50. Bio Products Laboratory (BPL) Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Kedrion Plasma-derived Therapies Product Specification

Table 52. Kedrion Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Shire Plasma-derived Therapies Product Specification

Table 54. Table Shire Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Octaparma Plasma-derived Therapies Product Specification

Table 56. Octaparma Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Bayer Plasma-derived Therapies Product Specification

Table 58. Bayer Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Grifols Plasma-derived Therapies Product Specification

Table 60. Grifols Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Biotest Plasma-derived Therapies Product Specification

Table 62. Biotest Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Takeda Plasma-derived Therapies Product Specification

Table 64. Takeda Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. LFB Plasma-derived Therapies Product Specification

Table 66. LFB Plasma-derived Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Plasma-derived Therapies Production Capacity by Market Players

Table 148. Global Plasma-derived Therapies Production by Market Players (2016-2021)

Table 149. Global Plasma-derived Therapies Production Market Share by Market Players (2016-2021)

Table 150. Global Plasma-derived Therapies Revenue by Market Players (2016-2021)

Table 151. Global Plasma-derived Therapies Revenue Share by Market Players (2016-2021)

Table 152. Global Market Plasma-derived Therapies Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 155. North America Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Plasma-derived Therapies Market Share by Type (2016-2021)

Table 157. North America Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Plasma-derived Therapies Market Share by Application (2016-2021)

Table 159. East Asia Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 162. East Asia Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Plasma-derived Therapies Market Share by Type (2016-2021)

Table 164. East Asia Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Plasma-derived Therapies Market Share by Application (2016-2021)

Table 166. Europe Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 169. Europe Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Plasma-derived Therapies Market Share by Type (2016-2021)

Table 171. Europe Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Plasma-derived Therapies Market Share by Application (2016-2021)

Table 173. South Asia Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 176. South Asia Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Plasma-derived Therapies Market Share by Type (2016-2021)

Table 178. South Asia Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Plasma-derived Therapies Market Share by Application (2016-2021)

Table 180. Southeast Asia Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 183. Southeast Asia Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Plasma-derived Therapies Market Share by Type (2016-2021)

Table 185. Southeast Asia Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Plasma-derived Therapies Market Share by Application (2016-2021)

Table 187. Middle East Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 190. Middle East Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Plasma-derived Therapies Market Share by Type (2016-2021)

Table 192. Middle East Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Plasma-derived Therapies Market Share by Application (2016-2021)

Table 194. Africa Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 197. Africa Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Plasma-derived Therapies Market Share by Type (2016-2021)

Table 199. Africa Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Plasma-derived Therapies Market Share by Application (2016-2021)

Table 201. Oceania Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 204. Oceania Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Plasma-derived Therapies Market Share by Type (2016-2021)

Table 206. Oceania Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Plasma-derived Therapies Market Share by Application (2016-2021)

Table 208. South America Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 211. South America Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Plasma-derived Therapies Market Share by Type (2016-2021)

Table 213. South America Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Plasma-derived Therapies Market Share by Application (2016-2021)

Table 215. Rest of the World Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Plasma-derived Therapies Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Plasma-derived Therapies Market Share (2016-2021)

Table 218. Rest of the World Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Plasma-derived Therapies Market Share by Type (2016-2021)

Table 220. Rest of the World Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Plasma-derived Therapies Market Share by Application (2016-2021)

Table 222. North America Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 223. East Asia Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 224. Europe Plasma-derived Therapies Consumption by Region (2016-2021)

Table 225. South Asia Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 226. Southeast Asia Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 227. Middle East Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 228. Africa Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 229. Oceania Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 230. South America Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 231. Rest of the World Plasma-derived Therapies Consumption by Countries (2016-2021)

Table 232. Global Plasma-derived Therapies Production Forecast by Region (2022-2027)

Table 233. Global Plasma-derived Therapies Sales Volume Forecast by Type (2022-2027)

Table 234. Global Plasma-derived Therapies Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Plasma-derived Therapies Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Plasma-derived Therapies Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Plasma-derived Therapies Sales Price Forecast by Type (2022-2027)

Table 238. Global Plasma-derived Therapies Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Plasma-derived Therapies Consumption Value Forecast by Application (2022-2027)

Table 240. North America Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 241. East Asia Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 242. Europe Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 243. South Asia Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 245. Middle East Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 246. Africa Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 247. Oceania Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 248. South America Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Plasma-derived Therapies Consumption Forecast 2022-2027 by Country

Table 250. Global Plasma-derived Therapies Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Plasma-derived Therapies Revenue Market Share by Type (2016-2021)

Table 252. Global Plasma-derived Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Plasma-derived Therapies Revenue Market Share by Type (2022-2027)

Table 254. Global Plasma-derived Therapies Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Plasma-derived Therapies Revenue Market Share by Application (2016-2021)

Table 256. Global Plasma-derived Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Plasma-derived Therapies Revenue Market Share by Application (2022-2027)

Table 258. Plasma-derived Therapies Distributors List

Table 259. Plasma-derived Therapies Customers List





Figure 1. Product Figure

Figure 2. Global Plasma-derived Therapies Market Share by Type: 2021 VS 2027

Figure 3. Global Plasma-derived Therapies Market Share by Application: 2021 VS 2027

Figure 4. North America Plasma-derived Therapies Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 6. North America Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 7. United States Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 8. Canada Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 12. China Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 13. Japan Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 15. Europe Plasma-derived Therapies Consumption and Growth Rate

Figure 16. Europe Plasma-derived Therapies Consumption Market Share by Region in 2021

Figure 17. Germany Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 19. France Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 20. Italy Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 21. Russia Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 22. Spain Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 25. Poland Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Plasma-derived Therapies Consumption and Growth Rate

Figure 27. South Asia Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 28. India Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Plasma-derived Therapies Consumption and Growth Rate

Figure 30. Southeast Asia Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 31. Indonesia Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Plasma-derived Therapies Consumption and Growth Rate

Figure 37. Middle East Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 38. Turkey Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 40. Iran Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 42. Africa Plasma-derived Therapies Consumption and Growth Rate

Figure 43. Africa Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 44. Nigeria Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Plasma-derived Therapies Consumption and Growth Rate

Figure 47. Oceania Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 48. Australia Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 49. South America Plasma-derived Therapies Consumption and Growth Rate

Figure 50. South America Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 51. Brazil Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Plasma-derived Therapies Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Plasma-derived Therapies Consumption and Growth Rate

Figure 54. Rest of the World Plasma-derived Therapies Consumption Market Share by Countries in 2021

Figure 55. Global Plasma-derived Therapies Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Plasma-derived Therapies Price and Trend Forecast (2022-2027)

Figure 58. North America Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 59. North America Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 75. South America Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Plasma-derived Therapies Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Plasma-derived Therapies Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 79. East Asia Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 80. Europe Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 81. South Asia Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 82. Southeast Asia Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 83. Middle East Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 84. Africa Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 85. Oceania Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 86. South America Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 87. Rest of the world Plasma-derived Therapies Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Plasma-derived Therapies

Figure 89. Manufacturing Process Analysis of Plasma-derived Therapies

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Plasma-derived Therapies Supply Chain Analysis